

[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
Liana Moussatos Reiterated (VRNA) at Buy and Held Target at $33 on, Mar 1st, 2024
Liana Moussatos of Wedbush, Reiterated "Verona Pharma plc" (VRNA) at Buy and Held Target at $33 on, Mar 1st, 2024.
Liana has made no other calls on VRNA in the last 4 months.
There is 1 other peer that has a rating on VRNA. Out of the 1 peers that are also analyzing VRNA, 0 agree with Liana's Rating of Hold.
This is the rating of the analyst that currently disagrees with Liana
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $32 on, Monday, January 22nd, 2024
Contributing Sources